Literature DB >> 2164767

Islet cell neoplasms. A fine-needle aspiration cytology study with immunocytochemical correlations.

J A Shaw1, R P Vance, K R Geisinger, R B Marshall.   

Abstract

Islet cell neoplasms (ICNs) are uncommon tumors that may present with bizarre endocrine manifestations. Only rarely have their fine-needle aspiration (FNA) cytomorphologic characteristics been reported. The authors have studied FNAs of ICNs in ten patients, including immunocytochemistry (ICC) directly on the aspirates. FNA yielded moderately to markedly cellular specimens with numerous individual cells and large aggregates. Although moderate pleomorphism was present in three cases, striking uniformity in nuclear size and contour and in delicate nuclear membranes was evident. Typically the round nuclei were eccentric, imparting a plasmacytoid appearance. Cytoplasmic granularity was noted in only a minority of tumor cells. Five of the ICNs were positive for chromogranin (CG). In comparison, seven ICNs were positive for CG in tissue sections. None of the cytologic material showed immunoreactivity with insulin, glucagon, somatostatin, or gastrin. Histologic material showed positivity for these hormones in 33% (three of nine), 22% (two of nine), 22% (two of nine), and 11% (one of nine), respectively. Although CG is the most useful immunocytochemical marker for ICNs, and thus is helpful in confirming a diagnosis of ICN in FNA material, it is negative in half of the cases and may be negative when the histologic material is positive.

Entities:  

Mesh:

Year:  1990        PMID: 2164767     DOI: 10.1093/ajcp/94.2.142

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  2 in total

Review 1.  My approach to pancreatic fine needle aspiration.

Authors:  Gladwyn Leiman
Journal:  J Clin Pathol       Date:  2006-05-12       Impact factor: 3.411

2.  Minute malignant islet cell tumor of the pancreas: report of a case.

Authors:  K Soda; S Yamada; T Yamanaka; A Kashii; M Miyata
Journal:  Surg Today       Date:  1995       Impact factor: 2.549

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.